240 related articles for article (PubMed ID: 21479566)
1. Effect of preoperative neutrophil-lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy.
Hung HY; Chen JS; Yeh CY; Changchien CR; Tang R; Hsieh PS; Tasi WS; You JF; You YT; Fan CW; Wang JY; Chiang JM
Int J Colorectal Dis; 2011 Aug; 26(8):1059-65. PubMed ID: 21479566
[TBL] [Abstract][Full Text] [Related]
2. Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer.
Ding PR; An X; Zhang RX; Fang YJ; Li LR; Chen G; Wu XJ; Lu ZH; Lin JZ; Kong LH; Wan DS; Pan ZZ
Int J Colorectal Dis; 2010 Dec; 25(12):1427-33. PubMed ID: 20821217
[TBL] [Abstract][Full Text] [Related]
3. Preoperative neutrophil-to-lymphocyte ratio predicts clinical outcome in patients with stage II and III colon cancer.
Absenger G; Szkandera J; Stotz M; Postlmayr U; Pichler M; Ress AL; Schaberl-Moser R; Loibner H; Samonigg H; Gerger A
Anticancer Res; 2013 Oct; 33(10):4591-4. PubMed ID: 24123035
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the efficacy of adjuvant chemotherapy in patients with high-risk stage II colon cancer.
Cakar B; Varol U; Junushova B; Muslu U; Gursoy Oner P; Gokhan Surmeli Z; Cirak Y; Karaca B; Sezgin C; Karabulut B; Uslu R
J BUON; 2013; 18(2):372-6. PubMed ID: 23818348
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of Lymphocyte Counts in Colon Cancer Patients Treated with FOLFOX Chemotherapy.
Noh OK; Oh SY; Kim YB; Suh KW
World J Surg; 2017 Nov; 41(11):2898-2905. PubMed ID: 28707088
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of tumor-infiltrating lymphocytes and neutrophil-to-lymphocyte ratio in patients with stage III colon cancer who underwent surgery followed by FOLFOX chemotherapy.
Cha YJ; Park EJ; Baik SH; Lee KY; Kang J
Sci Rep; 2019 Aug; 9(1):11617. PubMed ID: 31406179
[TBL] [Abstract][Full Text] [Related]
7. The relationship between right-sided tumour location, tumour microenvironment, systemic inflammation, adjuvant therapy and survival in patients undergoing surgery for colon and rectal cancer.
Patel M; McSorley ST; Park JH; Roxburgh CSD; Edwards J; Horgan PG; McMillan DC
Br J Cancer; 2018 Mar; 118(5):705-712. PubMed ID: 29337962
[TBL] [Abstract][Full Text] [Related]
8. Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer.
Kim CG; Ahn JB; Jung M; Beom SH; Heo SJ; Kim JH; Kim YJ; Kim NK; Min BS; Koom WS; Kim H; Roh YH; Ma BG; Shin SJ
Ann Surg Oncol; 2017 Jan; 24(1):227-235. PubMed ID: 27699609
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemotherapy with tegafur/uracil for more than 1 year improves disease-free survival for low-risk Stage II colon cancer.
Hu JM; Chou YC; Wu CC; Hsiao CW; Lee CC; Chen CT; Hu SI; Liu WT; Jao SW
J Chin Med Assoc; 2016 Sep; 79(9):477-88. PubMed ID: 27329402
[TBL] [Abstract][Full Text] [Related]
10. [An elevated neutrophil/lymphocyte ratio is associated with poor prognosis in stage II resected colon cancer].
Urrejola GI; Bambs CE; Espinoza MA; Gellona J; Zúñiga AM; Molina ME; Bellolio F; Miguieles R; Campbell JM; Pinedo GA
Rev Med Chil; 2013 May; 141(5):602-8. PubMed ID: 24089275
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Implications of Endoscopic Obstruction in Patients with Pathological Stage II Colon Cancers: a Single-Center Retrospective Cohort Study.
Mo TW; Zhang ZJ; Shi YQ; Xiang HD; Chen YL; Chen ZX; Hu JC; He XW
J Gastrointest Surg; 2023 Jan; 27(1):141-151. PubMed ID: 36352061
[TBL] [Abstract][Full Text] [Related]
12. Peripheral Neutrophil to Lymphocyte Ratio Improves Prognostication in Colon Cancer.
Rashtak S; Ruan X; Druliner BR; Liu H; Therneau T; Mouchli M; Boardman LA
Clin Colorectal Cancer; 2017 Jun; 16(2):115-123.e3. PubMed ID: 28365393
[TBL] [Abstract][Full Text] [Related]
13. T4 stage and preoperative anemia as prognostic factors for the patients with colon cancer treated with adjuvant FOLFOX chemotherapy.
An MS; Yoo JH; Kim KH; Bae KB; Choi CS; Hwang JW; Kim JH; Kim BM; Kang MS; Oh MK; Hong KH
World J Surg Oncol; 2015 Feb; 13():64. PubMed ID: 25889520
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of preoperative fibrinogen in patients with colon cancer.
Sun ZQ; Han XN; Wang HJ; Tang Y; Zhao ZL; Qu YL; Xu RW; Liu YY; Yu XB
World J Gastroenterol; 2014 Jul; 20(26):8583-91. PubMed ID: 25024612
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of preoperative prognostic nutritional index and its associations with systemic inflammatory response markers in patients with stage III colon cancer.
Peng J; Zhang R; Zhao Y; Wu X; Chen G; Wan D; Lu Z; Pan Z
Chin J Cancer; 2017 Dec; 36(1):96. PubMed ID: 29268783
[TBL] [Abstract][Full Text] [Related]
17. Elevated postoperative carcinoembryonic antigen guides adjuvant chemotherapy for stage II colon cancer: a multicentre cohort retrospective study.
Pu H; Yang W; Liu M; Pang X; Chen Y; Xiong Q
Sci Rep; 2024 Mar; 14(1):6889. PubMed ID: 38519578
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil to lymphocyte ratio is a strong predictor of tumor recurrence in early colon cancers: A propensity score-matched analysis.
Galizia G; Lieto E; Zamboli A; De Vita F; Castellano P; Romano C; Auricchio A; Cardella F; De Stefano L; Orditura M
Surgery; 2015 Jul; 158(1):112-20. PubMed ID: 25818659
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Significance of Combination of Preoperative Platelet Count and Neutrophil-Lymphocyte Ratio (COP-NLR) in Patients with Non-Small Cell Lung Cancer: Based on a Large Cohort Study.
Zhang H; Zhang L; Zhu K; Shi B; Yin Y; Zhu J; Yue D; Zhang B; Wang C
PLoS One; 2015; 10(5):e0126496. PubMed ID: 25950176
[TBL] [Abstract][Full Text] [Related]
20. Systemic Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker for Colon Cancer.
Iaciu CI; Emilescu RA; Cotan HT; Nitipir C
Chirurgia (Bucur); 2023 Jun; 118(3):260-271. PubMed ID: 37480352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
